ICW Investment Advisors LLC has filed a Form 13F-HR with the Securities and Exchange Commission, disclosing its equity portfolio as of September 30, 2026. The filing lists 143 separate equity positions held by the firm.
The report identifies AbbVie Inc. as the largest individual stock holding, with 6,266,669 shares. Other notable positions include Abbott Laboratories (2,890,677 shares), Amazon.com Inc. (5,540,449 shares), Broadcom Inc. (6,386,998 shares), and Coca-Cola Co. (2,992,456 shares). The portfolio also includes significant stakes in Microsoft Corporation (8,825,644 shares), Eli Lilly & Co. (3,847,564 shares), and Novo Nordisk A S ADR (1,685,257 shares).
In addition to individual equities, the filing lists several exchange-traded funds (ETFs) held by the firm. These include the Invesco S&P 500 Equal Weight ETF (984,585 shares), the Invesco QQQ Trust Unit Series 1 (1,465,927 shares), and the iShares Core S&P 500 ETF (201,151 shares). The filing was signed by Vincent Rossi, President of ICW Investment Advisors.
